|

Arthritis Clinical Trials in Ohio

30 recruiting studies across 2 cities

Browse by City

Cleveland
22 trials
Columbus
12 trials

All Trials in Ohio

Phase
Trial Phase Dist.
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
Preventing Injured Knees From osteoArthritis: Severity OutcomesPhase 2<1 mi
The Myelin Disorders Biorepository Project—<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)Phase 2<1 mi
MOTION Clinical TrialN/A<1 mi
IMPACT - AndHealth Autoimmune Research Registry—<1 mi
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic PainPhase 2<1 mi
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisPhase 3<1 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPhase 3<1 mi
Persona Revision Knee System Outcomes—<1 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisPhase 3<1 mi
Improving Total Knee Arthroplasty Dissatisfaction Through a Personalized Approach Focusing on PROMs PhenotypesN/A<1 mi
Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry—<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).Phase 1<1 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 3<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 3<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesPhase 3<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 2<1 mi
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension—<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic ArthritisPhase 4<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 311 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic ArthritisPhase 211 mi
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisPhase 211 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 211 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Phase 411 mi
Continuation Study of Zasocitinib in Adults With Psoriatic ArthritisPhase 311 mi
Safety and Effectiveness of the HIT Reverse HRSN/A13 mi
Exactech Shoulder Post Market Clinical Follow-up Study—30 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.